XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net revenues (Tables)
 3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of revenue by major customers by reporting segments
The following table disaggregates revenue by global product category for the three months ended March 31, 2024 and April 2, 2023.
Three Months Ended
March 31, 2024April 2, 2023
Vascular access$181,354 $177,652 
Interventional
134,665 116,897 
Anesthesia96,352 93,332 
Surgical105,524 99,023 
Interventional urology79,742 75,378 
OEM87,697 76,997 
Other (1)
52,515 71,653 
Net revenues (2)
$737,849 $710,932 
(1)    Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products) and sales pursuant to the manufacturing and supply transition agreement related to our Respiratory business divestiture.
(2)    The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments includes net revenues from each of the non-OEM product categories listed above.